Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
86
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

Jose M Marin1 University Hospital Miguel Servet, IISAragón, CIBERES, Zaragoza, Spain
,
Kai M Beeh2 Insaf Respiratory Research Institute, Wiesbaden, Germany
,
Andreas Clemens3 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
,
Walter Castellani4 Hospital Piero Palagi, Fiorenze, Italy
,
Lennart Schaper5 Research Institute and Practice, Berlin-Brandenburg, Germany
,
Dinesh Saralaya6 Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
,
Anthony Gunstone7 Staploe Medical Center, Soham, Cambridge, UK
,
Ricard Casamor8 Novartis Farmaceutica SA, Barcelona, Spain
,
Konstantinos Kostikas3 Novartis Pharma AG, Basel, Switzerland
&
Maryam Aalamian-Mattheis3 Novartis Pharma AG, Basel, Switzerland
 show all
Pages 1425-1434 | Published online: 28 Jun 2016

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Tian Sun, Xiaoyun Li, Wei Cheng, Yating Peng, Yiyang Zhao, Cong Liu, Yuqin Zeng, Yan Chen, Shan Cai & Ping Chen. (2020) The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1899-1907.
Read now
Alexa Núñez, Cristina Esquinas, Miriam Barrecheguren, Myriam Calle, Ricard Casamor & Marc Miravitlles. (2018) Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3837-3844.
Read now
Donald P Tashkin & Nicholas J Gross. (2018) Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1873-1888.
Read now
Amanda R van Buul, Marise J Kasteleyn, Niels H Chavannes & Christian Taube. (2017) The association between objectively measured physical activity and morning symptoms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2831-2840.
Read now
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Review of Respiratory Medicine 11:4, pages 311-322.
Read now

Articles from other publishers (10)

Wei-Chang Huang, Sheng-Hao Lin, Liang-Wen Hang, Ching-Hsiung Lin & Jeng-Yuan Hsu. (2022) The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan. Journal of Clinical Medicine 11:20, pages 6210.
Crossref
Nalini Jayanthi, Karthickeyan Krishnan, Manali Sudhir, S. Girija, Nishi P A & Sathish Kumar J. (2022) Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease. Contemporary Clinical Trials Communications 28, pages 100931.
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Ioanna Tsiligianni & Janwillem W. H. Kocks. (2020) Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. npj Primary Care Respiratory Medicine 30:1.
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Kenneth R. Chapman, John R. Hurst, Robert B. Fogel, Pascal Pfister, Konstantinos Kostikas & Jadwiga A. Wedzicha. (2019) Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion. American Journal of Respiratory and Critical Care Medicine 199:3, pages 390-392.
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2018) Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms. Respiratory Research 19:1.
Crossref
Emmanuel Naline, Stanislas Grassin Delyle, Hélène Salvator, Marion Brollo, Christophe Faisy, Tatiana Victoni, Charlotte Abrial & Philippe Devillier. (2018) Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus. Pulmonary Pharmacology & Therapeutics 49, pages 46-53.
Crossref
L. A. Shpagina, I. S. Shpagin, O. S. Kotova, T. I. Pospelova & O. N. Gerasimenko. (2017) Treatment of different phenotypes of chronic obstructive pulmonary disease. PULMONOLOGIYA 26:6, pages 681-693.
Crossref
Henrik Watz, Claudia Mailänder, Christoph May, Monika Baier & Anne-Marie Kirsten. (2017) Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD — A randomised, multicentre, crossover trial. Pulmonary Pharmacology & Therapeutics 42, pages 13-20.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.